Update on Antithrombotic Agents in Secondary Stroke PreventionReportar como inadecuado

Update on Antithrombotic Agents in Secondary Stroke Prevention - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Acta clinica Croatica, Vol.50 No.1 March 2011. -

Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.

Stroke - prevention and control; Secondary prevention; Platelet aggregation inhibitors - therapeutic use; Anticoagulants

Autor: Tatjana Rundek - ; Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA Vanja Bašić-Kes - ; U

Fuente: http://hrcak.srce.hr/


Documentos relacionados